The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...

(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...

LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose ...

Seven stunning romantic canal cities offer waterside history, architecture, and atmosphere without Venice's crowds or prices.